Relief for Remote ID: The FAA Extends Compliance Deadline for Drone Operators
Client Alert | 1 min read | 09.15.23
With days to spare, the FAA has officially extended the deadline for drone operators in the U.S. to comply with Remote ID equipage and transmission requirements by six (6) months, until March 16, 2024. The original compliance date of September 16, 2023 was seen as unattainable by many drone operators due to the FAA’s slow approval of manufacturer Declarations of Compliance and unavailability of software updates from manufacturers.
The FAA has made clear that this is the last extension that will be granted, and that operators who remain non-compliant by March 16, 2024 could be subject to enforcement action in the form of monetary fines and suspension or revocation of pilot certificates. Therefore, operators should continue to work diligently to comply, despite this extension.
Additional coverage on Remote ID for manufacturers and operators can be found here and here.
Contacts
Senior Counsel
She/Her/Hers
Insights
Client Alert | 4 min read | 04.10.25
Hikma and Amici Curiae Ask Supreme Court to Revisit Induced Infringement by Generic “Skinny Labels”
In Amarin Pharma, Inc. v. Hikma Pharms. USA Inc., C.A. No. 20-1630 (D. Del.), brand manufacturer Amarin brought an induced infringement claim against Hikma’s generic icosapent ethyl product, which lists Amarin’s Vascepa® as the reference listed drug. Vascepa was originally approved by the U.S. Food and Drug Administration (“FDA”) to treat severe hypertriglyceridemia, and later, Amarin obtained patents and approval for Vascepa as a treatment to reduce cardiovascular risk in certain patient populations. Hikma’s Abbreviated New Drug Application (“ANDA”) for generic icosapent ethyl included a Section viii statement that Hikma was not seeking approval for the patented cardiovascular indication along with a “skinny label” that included only the indication for severe hypertriglyceridemia.
Client Alert | 1 min read | 04.09.25
Client Alert | 12 min read | 04.09.25
Client Alert | 4 min read | 04.07.25
